Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

TG 01 - Targovax

Next Previous
X
Search
Drug Profile

TG 01 - Targovax

Alternative Names: TG01 - Targovax

Latest Information Update: 18 Sep 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Norsk Hydro; Norwegian Radium Hospital
  • Developer Georgetown University; Targovax
  • Class Antineoplastics; Cancer vaccines; Immunotherapies; Peptide vaccines
  • Mechanism of Action Immunostimulants; Ras gene modulators; T lymphocyte stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Pancreatic cancer
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Non-small cell lung cancer; Pancreatic cancer
  • Phase I/II Smoldering multiple myeloma

Most Recent Events

  • 13 Jun 2024 Adverse events and efficacy data from a phase I/II trial in Smoldering multiple myeloma presented at the 29th Congress of the European Haematology Association (EHA-2024)
  • 01 Dec 2023 Phase-II clinical trials in Non-small cell lung cancer (Second-line therapy or greater, Late-stage disease) in USA (Parenteral) (NCT06015724)
  • 01 Dec 2023 Phase-II clinical trials in Pancreatic cancer (Second-line therapy or greater) in USA (Parenteral) (NCT06015724)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top